US Patent Issued to The Board of Trustees of the University of Illinois, The Regents of the University of California on April 29 for "Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases" (Illinois, California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,407, issued on April 29, was assigned to The Board of Trustees of the University of Illinois (Urbana, Ill.) and The Regents of the University of California (Oakland, Calif.).

"Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases" was invented by John A. Katzenellenbogen (Urbana, Ill.), Seema K. Tiwari-Woodruff (Riverside, Calif.), Sung Hoon Kim (Champaign, Ill.) and Benita Katzenellenbogen (Urbana, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "4-Hydroxyphenyl-2H-indazol-5-ol compounds are estrogen receptor beta ligands that have immunomodu...